These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1605236)

  • 21. Mental status and fragile X expression in relation to FMR-1 gene mutation.
    de Vries BB; Wiegers AM; de Graaff E; Verkerk AJ; Van Hemel JO; Halley DJ; Fryns JP; Curfs LM; Niermeijer MF; Oostra BA
    Eur J Hum Genet; 1993; 1(1):72-9. PubMed ID: 8069653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A step-wise diagnosis of fragile X syndrome in Taiwan.
    Huang YT; Chiang SC; Tzeng CC; Liu CH; Chien YH; Hwu WL
    Acta Paediatr Taiwan; 2004; 45(2):69-72. PubMed ID: 15335113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maximizing the sensitivity of a screening questionnaire for determining Fragile X at-risk status.
    Teisl JT; Reiss AL; Mazzocco MM
    Am J Med Genet; 1999 Apr; 83(4):281-5. PubMed ID: 10208162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular biologic screening test (PCR) for fragile X syndrome].
    Kovács E; Morava E; Nádasi E; Czakó M; Melegh B; Kosztolányi G
    Orv Hetil; 1998 Dec; 139(52):3121-3. PubMed ID: 9914733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular diagnosis of fragile X syndrome using methylation sensitive techniques in a cohort of patients with intellectual disability.
    Chaudhary AG; Hussein IR; Abuzenadah A; Gari M; Bassiouni R; Sogaty S; Lary S; Al-Quaiti M; Al Balwi M; Al Qahtani M
    Pediatr Neurol; 2014 Apr; 50(4):368-76. PubMed ID: 24630283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fragile X syndrome. Diagnosis, genetics and clinical findings].
    Hjalgrim H; Grønskov K; Brøndum-Nielsen K
    Ugeskr Laeger; 1998 Sep; 160(37):5330-4. PubMed ID: 9748856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The diagnosis of mental retardation in fragile X syndrome is revolutionized by molecular genetics].
    Lemire M; Rousseau F
    Union Med Can; 1993; 122(1):23-9. PubMed ID: 8465472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic checklist to screen for fragile X syndrome in people with mental retardation.
    Maes B; Fryns JP; Ghesquière P; Borghgraef M
    Ment Retard; 2000 Jun; 38(3):207-15. PubMed ID: 10900928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for fragile X syndrome among Brazilian mentally retarded male patients using PCR from buccal cell DNA.
    Christofolini DM; Lipay MV; Ramos MA; Brunoni D; Melaragno MI
    Genet Mol Res; 2006 Jul; 5(3):448-53. PubMed ID: 17117359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specification of the neurobehavioral phenotype in males with fragile X syndrome.
    Baumgardner TL; Reiss AL; Freund LS; Abrams MT
    Pediatrics; 1995 May; 95(5):744-52. PubMed ID: 7724315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic testing in fragile X syndrome].
    Sireteanu A; Rusu C
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):968-71. PubMed ID: 17438909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and molecular screening for fragile X syndrome in 300 patients with non-specific mental retardation].
    Jara L; López M; Mellado C; Aspillaga M; Avendaño I; Blanco R
    Rev Med Chil; 1998 Aug; 126(8):911-8. PubMed ID: 9830742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular genetic advances in fragile X syndrome.
    Tarleton JC; Saul RA
    J Pediatr; 1993 Feb; 122(2):169-85. PubMed ID: 8429429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Psychopathology in female carriers of the fragile X mutation].
    Hageman S; Van Den Eede F; Vandendriessche F; Claes S
    Tijdschr Psychiatr; 2007; 49(5):327-31. PubMed ID: 17492583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for fragile X syndrome: results from a school for mentally retarded children.
    Hećimović S; Tarnik IP; Barić I; Cakarun Z; Pavelić K
    Acta Paediatr; 2002; 91(5):535-9. PubMed ID: 12113322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular diagnosis of fragile X syndrome].
    Ben Jemaa L; Khemir S; Maazoul F; Richard L; Beldjord C; Chaabouni M; Chaabouni H
    Tunis Med; 2008 Nov; 86(11):973-7. PubMed ID: 19213487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular/clinical correlations in females with fragile X.
    Sobesky WE; Taylor AK; Pennington BF; Bennetto L; Porter D; Riddle J; Hagerman RJ
    Am J Med Genet; 1996 Aug; 64(2):340-5. PubMed ID: 8844077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive and molecular aspects of fragile X.
    Hinton VJ; Halperin JM; Dobkin CS; Ding XH; Brown WT; Miezejeski CM
    J Clin Exp Neuropsychol; 1995 Aug; 17(4):518-28. PubMed ID: 7593472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for fragile X syndrome.
    Murray J; Cuckle H; Taylor G; Hewison J
    Health Technol Assess; 1997; 1(4):i-iv, 1-71. PubMed ID: 9414543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotype, molecular phenotype, and cognitive phenotype: correlations in fragile X syndrome.
    Kaufmann WE; Abrams MT; Chen W; Reiss AL
    Am J Med Genet; 1999 Apr; 83(4):286-95. PubMed ID: 10208163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.